Table 1 Baseline characteristics
Participant characteristics | Intervention Self-monitoring N = 10 | Control Usual care N = 5 | Total N = 15 |
|---|---|---|---|
Demographics | |||
 Age, mean (SD) | 69 (7.1) | 71.2 (8.7) | 70 (7.4) |
 Male, n (%) | 8 (80%) | 4 (80%) | 12 (80%) |
 Lives alone, n (%) | 6 (60%) | 2 (40%) | 8 (53.3%) |
 Helped by carer, n (%) | 3 (30%) | 1 (20%) | 4 (26.7%) |
 Stroke, n (%) | 7 (70%) | 4 (80%) | 11 (73.3%) |
 TIA, n (%) | 3 (30%) | 1 (20%) | 4 (26.7%) |
Education (highest level achieved) | |||
 Primary education only, n (%) | 2 (20%) | 1 (20%) | 3 (20%) |
 Secondary school certificate, n (%) | 3 (30%) | 2 (40%) | 5 (33.3%) |
 University degree or higher, n (%) | 4 (40%) | 2 (40%) | 6 (40%) |
 Diploma/other qualification, n (%) | 1 (10%) | 0 | 1 (6.7%) |
Comorbiditiesa | |||
 Myocardial infarction, n (%) | 0 | 1 (20%) | 1 (6.7%) |
 Angina, n (%) | 0 | 1 (20%) | 1 (6.7%) |
 CABG/angioplasty (balloon)/stent, n (%) | 3 (30%) | 1 (20%) | 4 (26.7%) |
 Peripheral Vascular Disease, n (%) | 0 | 0 | 0 |
 Diabetes—type 1, n (%) | 0 | 0 | 0 |
 Diabetes—type 2, n (%) | 1 (10%) | 1 (20%) | 2 (13.3%) |
 Heart failure, n (%) | 0 | 0 | 0 |
Current antihypertensive medication | |||
 0, n (%) | 0 | 0 | 0 |
 1, n (%) | 4 (40%) | 1 (20%) | 5 (33.3%) |
 2, n (%) | 6 (60%) | 4 (80%) | 10 (66.7%) |
 Range | 1–2 | 1–2 | 1–2 |